- Filed
- May 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 5, 2025 | 230.75M sh |
| Short Term Debt | Q1 2025 · Apr 5, 2025 | $160M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $225M |
| Short Term Investments | Q1 2025 · Apr 5, 2025 | $905M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $581M |
| Cash And Equivalents | Q1 2025 · Apr 5, 2025 | $3.16B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $3.56B |
| Stockholders Equity | Q1 2025 · Apr 5, 2025 | $20.07B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $20.29B |
| Current Liabilities | Q1 2025 · Apr 5, 2025 | $5.06B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $4.98B |
| Total Liabilities | Q1 2025 · Apr 5, 2025 | $13.58B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $12.52B |
| Current Assets | Q1 2025 · Apr 5, 2025 | $12.76B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $12.48B |
| Total Assets | Q1 2025 · Apr 5, 2025 | $34.7B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $33.94B |
| Shares Diluted restated | Q1 2025 · Mar 30, 2024 | 243.5M sh |
| Stock Repurchased restated | Q1 2025 · Mar 30, 2024 | $1B |
| Dividends Paid restated | Q1 2025 · Mar 30, 2024 | $134M |
| Capex restated | Q1 2025 · Mar 30, 2024 | $670M |
| Operating Cash Flow restated | Q1 2025 · Mar 30, 2024 | $460M |
| Eps Diluted | Q1 2025 · Mar 30, 2024 | $3.46 |
| Eps Basic | Q1 2025 · Mar 30, 2024 | $3.46 |
| Sga Expense restated | Q1 2025 · Mar 30, 2024 | $345M |
| Net Income restated | Q1 2025 · Mar 30, 2024 | $845M |
| Cost Of Revenue restated | Q1 2025 · Mar 30, 2024 | $6.61B |
| Revenue restated | Q1 2025 · Mar 30, 2024 | $8.14B |